Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease.

Cramer PE, Gentzel RC, Tanis KQ, Vardigan J, Wang Y, Connolly B, Manfre P, Lodge K, Renger JJ, Zerbinatti C, Uslaner JM.

Neurobiol Aging. 2018 Apr;64:92-106. doi: 10.1016/j.neurobiolaging.2017.12.011. Epub 2017 Dec 20.

PMID:
29353102
2.

TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.

Jinn S, Drolet RE, Cramer PE, Wong AH, Toolan DM, Gretzula CA, Voleti B, Vassileva G, Disa J, Tadin-Strapps M, Stone DJ.

Proc Natl Acad Sci U S A. 2017 Feb 28;114(9):2389-2394. doi: 10.1073/pnas.1616332114. Epub 2017 Feb 13.

3.

Response to comments on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Landreth GE, Cramer PE, Lakner MM, Cirrito JR, Wesson DW, Brunden KR, Wilson DA.

Science. 2013 May 24;340(6135):924-g. doi: 10.1126/science.1234114.

4.

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models.

Cramer PE, Cirrito JR, Wesson DW, Lee CY, Karlo JC, Zinn AE, Casali BT, Restivo JL, Goebel WD, James MJ, Brunden KR, Wilson DA, Landreth GE.

Science. 2012 Mar 23;335(6075):1503-6. doi: 10.1126/science.1217697. Epub 2012 Feb 9.

5.

Deletion of CD14 attenuates Alzheimer's disease pathology by influencing the brain's inflammatory milieu.

Reed-Geaghan EG, Reed QW, Cramer PE, Landreth GE.

J Neurosci. 2010 Nov 17;30(46):15369-73. doi: 10.1523/JNEUROSCI.2637-10.2010.

6.

Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's disease.

Wilkinson BL, Cramer PE, Varvel NH, Reed-Geaghan E, Jiang Q, Szabo A, Herrup K, Lamb BT, Landreth GE.

Neurobiol Aging. 2012 Jan;33(1):197.e21-32. doi: 10.1016/j.neurobiolaging.2010.06.014. Epub 2010 Aug 8.

Supplemental Content

Loading ...
Support Center